Ionis Pharmaceuticals | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Arrowhead Research -173085000 2.55M 2024-12
Astellas Pharma JPY 382.44B 36.45B 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Celltrion KRW 463.41B 95.59B 2024-09
Cspc Pharmaceutical CNY 4.33B 828.42M 2024-09
Ecofibre AUD 2.08M 4.33M 2024-06
Exelixis USD 546.79M 24.58M 2025-01
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Kangmei Pharma CNY 176.17M 370.88K 2024-09
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 13.36M 2.36M 2024-06
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Novartis USD 10.23B 294M 2024-12
OPKO Health USD 84.6M 44.47M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Pfizer USD 11.12B 987M 2025-03
Pharma Mar EUR 35.46M 11.59M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Qiagen NV USD 349.8M 19.17M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Sartorius EUR 431M 36.4M 2025-03
Sino Biopharmaceutical CNY 10.5B 3.99B 2024-12
Tilray USD 61.22M 1.51M 2024-11
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Zz Pientze Pharmaceu 1.39B 632.84M 2025-03



Ionis Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.